You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-ergot dopamine agonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pituitary Tumors, Adenoma Trial in Oslo, Trondheim, Gøteborg (cabergoline)

Recruiting
  • Pituitary Neoplasms
  • Adenoma
  • Oslo, Norway
  • +2 more
Jan 19, 2023

Hyperprolactinemia, Prolactinoma Trial in New York (Ropinirole)

Completed
Has Results
  • Hyperprolactinemia
  • Prolactinoma
  • New York, New York
    Columbia University Medical Center
Jul 9, 2021

Parkinson Disease Trial in Nashville (Pramipexole, Placebo)

Recruiting
  • Parkinson Disease
  • Nashville, Tennessee
    Vanderbilt University Medical Center
May 2, 2022

Overweight and Obesity, Eating Behavior Trial in Chapel Hill (Placebo, Bromocriptine-QR)

Completed
Has Results
  • Overweight and Obesity
  • Eating Behavior
  • Chapel Hill, North Carolina
    University of North Carolina, Chapel Hill
Aug 12, 2022

Health Trial in Edmonton (Dopamine, Metoclopramide, Placebos)

Recruiting
  • Health
  • Edmonton, Alberta, Canada
    Clinical Physiology Research Laboratory
Apr 6, 2022

Vigor and the LDR in Parkinson Disease

Recruiting
  • Parkinson Disease
  • carbidopa/levodopa, as prescribed by treating physician
  • Ann Arbor, Michigan
    University of Michigan
Dec 1, 2022

Parkinson Disease Trial in Lille (A-dopamine, optimized oral treatment)

Recruiting
  • Parkinson Disease
  • Lille, France
    Hopital Roger Salengro, CHU Lille
Oct 11, 2022

Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread Trial in Zürich (Low dose naltrexone, Placebo, Bromocriptine Mesylate

Recruiting
  • Fibromyalgia
  • +2 more
  • Low dose naltrexone
  • +3 more
  • Zürich, Switzerland
    Balgrist Campus
Feb 20, 2022

Substance-Related Disorders Trial in Richmond (Rotigotine Transdermal System [Neupro], Placebo)

Not yet recruiting
  • Substance-Related Disorders
  • Rotigotine Transdermal System [Neupro]
  • Placebo
  • Richmond, Virginia
    Virginia Commonwealth University
Jun 1, 2023

Parkinson Disease Trial in France (drug, behavioral, procedure)

Recruiting
  • Parkinson Disease
  • Active drug: pimavanserin 17mg (2 strength tablets)
  • +9 more
  • Besançon, France
  • +15 more
Jan 20, 2022

Impulse Control Disorder Trial in Korea, Republic of (Levodopa/Carbidopa(200mg/50mg), Dopaminergic Agonists)

Completed
  • Impulse Control Disorder
  • Anyang, Korea, Republic of
  • +4 more
Mar 9, 2021

MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

Recruiting
  • Major Depressive Disorder
  • Toludivenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Jun 14, 2023

Ergot Alkaloids in Treatment of Salivation in Parkinson's

Enrolling by invitation
  • Main Heading (Descriptor) Terms
  • Dihydroergot mesylate
  • Nanjing, Jiangsu, China
    Dihydroergot mesylate
Sep 6, 2023

Delirium Trial in Birmingham (Guanfacine, Placebo)

Recruiting
  • Delirium
  • Birmingham, Alabama
    University of Alabama at Birmingham Hospital
Nov 17, 2021

Parkinson Disease, Memory Impairment Trial in Beijing (Madopar monotherapy, senfrol monotherapy, monotherapy)

Recruiting
  • Parkinson Disease
  • Memory Impairment
  • Madopar monotherapy
  • +2 more
  • Beijing, China
    Peking University Third Hospital
Jul 8, 2021

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Endometriosis Trial (surveys (Fertiqol et SF36))

Not yet recruiting
  • Endometriosis
  • surveys (Fertiqol et SF36)
  • (no location specified)
Oct 26, 2023

Arterial Stiffness, Hypertension, Cardiovascular Diseases Trial in Prague (Cardiovascular fitness)

Active, not recruiting
  • Arterial Stiffness
  • +2 more
  • Cardiovascular fitness
  • Prague, Czechia
  • +1 more
Sep 14, 2023

Chronic Anergic-anhedonic Depression Open Trial

Recruiting
  • Depressive Disorder, Treatment-Resistant
    • Strasbourg, France
      CENTRE DE NEUROMODULATION NON INVASIVE DE STRASBOURG (CEMNIS) -
    Oct 25, 2023

    Obesity Trial in Cologne, Luebeck, Tübingen (Bromocriptine, Placebo)

    Recruiting
    • Obesity
    • Cologne, Germany
    • +2 more
    May 31, 2022

    Stress Response Trial (tDCS actif, tDCS Sham)

    Not yet recruiting
    • Stress Response
    • tDCS actif
    • tDCS Sham
    • (no location specified)
    Apr 20, 2023

    The Meaning of Dopaminergic Pathway in Sleep Breathing

    Enrolling by invitation
    • Sleep Apnea
    • Sleep-Disordered Breathing
    • Polysomnography
    • +2 more
    • Wroclaw, Poland
      Wroclaw Medical Uniwesity
    May 25, 2023

    Addiction Trial in Berkeley, San Francisco (Tolcapone, Placebo, Bromocriptine)

    Withdrawn
    • Addiction
    • Berkeley, California
    • +1 more
    Nov 12, 2021

    Parkinson Disease Trial in Porto Alegre (Leap Motion Controller on flat display, Leap Motion Controller in Head-Mounted Display)

    Recruiting
    • Parkinson Disease
    • Leap Motion Controller on flat display
    • Leap Motion Controller in Head-Mounted Display
    • Porto Alegre, RS, Brazil
      Universidade Federal de Ciências da Saúde de Porto Alegre
    Jan 7, 2023

    Parkinson Disease Trial in Porto Alegre (Leap Motion Controller on flat display)

    Not yet recruiting
    • Parkinson Disease
    • Leap Motion Controller on flat display
    • Porto Alegre, RS, Brazil
      Universidade Federal de Ciências da Saúde de Porto Alegre
    Jun 18, 2023